UBS Group’s CytoMed Therapeutics GDTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.6K | Buy |
17,581
+3,134
| +22% | +$7.05K | ﹤0.01% | 6663 |
|
|
2025
Q1 | $31.5K | Buy |
14,447
+4,349
| +43% | +$9.48K | ﹤0.01% | 6612 |
|
|
2024
Q4 | $34.3K | Buy |
10,098
+10,037
| +16,454% | +$34.1K | ﹤0.01% | 6301 |
|
|
2024
Q3 | $96 | Buy |
+61
| New | +$96 | ﹤0.01% | 7944 |
|
|
2024
Q1 | – | Sell |
-3,500
| Closed | -$17.2K | – | 8303 |
|
|
2023
Q4 | $17.2K | Buy |
3,500
+3,023
| +634% | +$14.8K | ﹤0.01% | 5993 |
|
|
2023
Q3 | $1.67K | Buy |
477
+423
| +783% | +$1.48K | ﹤0.01% | 6713 |
|
|
2023
Q2 | $165 | Buy |
+54
| New | +$165 | ﹤0.01% | 7347 |
|